Antioxidants modulate adenosine metabolism in rat mesangial cells cultured under high glucose conditions

Renal Failure

Volumn 24, Issue 6, 2002, Pages 691-701

  Kocic, G ^a,b   Djordjevic, V ^a   Vlahovic, P ^a   Kocic, R ^a   Pavlovic, D ^a   Jevtovic, T ^a  

^a UNIVERSITY OF NI   (Serbia)

^b Med Fac Institute of Biochemistry   (Yugoslavia)

Author keywords

5 Nucleotidase; Adenosine; Adenosine deaminase; Captopril; Diabetic nephropathy; Glutathione; Melatonin

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE DEAMINASE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLUTATHIONE; MELATONIN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CELL METABOLISM; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BLOOD FLOW; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIOXIDANTS; CAPTOPRIL; CELL CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; FIBROBLASTS; FREE RADICAL SCAVENGERS; GLOMERULAR MESANGIUM; GLUTATHIONE; HYPERGLYCEMIA; MELATONIN; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; VASODILATOR AGENTS;

EID: 0036442324     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120015665     Document Type: Article

References (46)

1. Buschaunsen, L.; Seibold, S.; Gross, O.; Matheaus, T.; Weber, M.; Schulze-Lohoff, E. Regulation of mesangial cell function by vasodilatory signaling molecules. Cardiovasc. Res. 2001, 51(3), 463-469.
2. Parving, H.H. Renoprotection in diabetes: Genetic and non-genetic risk factors and treatment. Diabetologia 1998, 41(7), 745-759.
3. Olivera, A.; Tomas, M.; Lopez-Novoa, J.M. Effect of adenosine A1 and A2 agonists and antagonists on cAMP and Ca2+ in cultured rat mesangial cells. Am. J. Physiol. 1992, 262(4), C840-C844.
4. Stefanovic, V.; Savic, V.; Vlahovic, P.; Ardallou, N. Ecto 5′-nucleotidase of cultured rat mesangial cells. Renal Physiol. Biochem. 1988, 11(1-2), 89-100.
5. Olivera, A.; Lamas, S.; Rodriguez-Puyol, D.; Lopez-Novoa, J.M. Adenosine induces mesangial cell contraction by an Al-type receptor. Kidney Int. 1989, 35(6), 1300-1305.
6. Spielman, W.S.; Thompson, C.I. A proposed role for adenosine in the regulation of renal hemodynamics and renin release. Am. J. Physiol. 1982, 242(5), F423-F435.
7. Kammer, G.M. Adenosine: Emerging role as an immunomodifying agent. J. Lab. Clin. Med. 1987, 110(3), 255-256.
8. Nosaka, K.; Takahashi, T.; Miyanoshita, A.; Nishi, T.; Suzuki, K.; Kurokawa, K.; Endou, H. Effect of adenosine on phorbol myristate acetate induced-reactive oxygen metabolite production in cultured mesangial cells. Free Rad. Biol. Med. 1996, 20(1), 151-155.
9. Schulze-Lohoff, E.; Ogilvie, A.; Sterzel, R.B. Extracellular nucleotides as signaling molecules for renal mesangial cells. J. Auton. Pharmacol. 1996, 16(6), 381-384.
10. Wakade, T.D.; Palmer, K.C.; McCauley, R.; Przywara, D.A.; Wakade, A.R. Adenosine-induced apoptosis in chick embryonic sympathetic neurons: A new physiological role of adenosine. J. Physiol. 1995, 488(Pt3), 123-138.
11. Kitakaze, M.; Hori, M. It is a time to ask what adenosine can do for cardioprotection. Heart Vessels 1998, 13(5), 211-228.
12. Fox, I.H.; Kelley, W.N. The role of adenosine and deoxyadenosine in mammalian cells. Ann. Rev. Biochem. 1978, 47, 655-686.
13. Foidart, J.B.; Dechenne, C.A.; Mahieu, P.; Creutz, C.E.; De Mey, J. Tissue culture of normal rat glomeruli. Isolation and morphological characterization of two homogenous cell lines. Invest. Cell. Pathol. 1979, 2(1), 15-26.
14. Wood, R.J.; Williams, D.G. Colorimetric determination of serum 5′-nucleotidase without deproteinization. Clin. Chem. 1981, 27(3), 464-465.
15. Kocic, G.; Vlahovic, P.; Pavlovic, D.; Kocic, R.; Jevtovic, T.; Cvetkovic, T.; Stojanovic, I. The possible importance of the cation-binding site for the oxidative modification of liver 5′-nucleotidase. Arch. Physiol. Biochem. 1998, 106(2), 91-99.
16. Kocic, G.; Pavlovic, D.; Jevtovic, T.; Kocić, R.; Bojić, A.; Djordjević, V.; Sokolović, D.; Djindjić, B. Oxidative modification of rat liver 5′-nucleotidase: The mechanisms of protection and reactivation. Arch. Physiol. Biochem. 2001, 109(4), 323-330.
17. Pederson, R.C.; Berry, A.J. Sensitive, optimized assay for serum AMP deaminase. Clin. Chem. 1977, 23(9), 1726-1733.
18. Lauber, K. Photometric determination of nitrogen. Wet incineration followed by formation of indophenol blue with salicylate/hypochlorite. Clin. Chim. Acta 1976, 67(1), 107-110.
19. Lowry, O.H.; Rosenbrough, N.J.; Farr, A.L.; Randall, R. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
20. Montecinos, V.P.; Aguayo, C.; Flores, C.; Wyatt, A.W.; Pearson, J.D.; Mann, G.E.; Sobrevia, L. Regulation of adenosine transport by D-glucose in human fetal endothelial cells: Involvement of nitric oxide, protein kinase C and mitogen-activated protein kinase. J. Physiol. 2000, 15(3), 777-790.
21. Olmo, N.; Turnay, J.; Risse, G.; Detzmann, R.; Von der Mark, K.; Lizarbe, M.A. Modulation of 5′-nucleotidase activity in plasma membranes and intact cells by the extracellular matrix proteins laminin and fibronectin. Biochem. J. 1992, 282(1), 181-188.
22. Stochaj, U.; Richter, H.; Mannherz, H.G. Chicken gizzard 5′-nucleotidase is a receptor for the extracellular matrix component fibronectin. Eur. J. Cell. Biol. 1990, 51(2), 335-338.
23. Dieckhoff, J.; Mollenhauer, J.; Kuhl, U.; Niggemeyer, B.; Von der Mark, K.; Mannherz, H.G. The extracellular matrix proteins laminin and fibronectin modify the AMP-ase activity of 5′-nucleotidase from chicken gizzard smooth muscle. FEBS Lett. 1986, 195(1-2), 82-86.
24. Baker, A.J.; Mooney, A.; Hughes, J.; Lombardi, D.; Johnson, R.J.; Savill, J. Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Invest. 1994, 94(5), 2105-2116.
25. Imura, T.; Shimohama, S. Opposing effects of adenosine on the survival of glial cells exposed to clinical ischemia. J. Neurosci. Res. 2000, 62(4), 539-546.
26. Benveniste, P.; Cohen, A. p53 expression is required for thymocyte apoptosis induced by adenosine deaminase deficiency. Proc. Natl. Acad. Sci. USA 1995, 92(18), 8373-8377.
27. Williams, B.; Schrier, R.W. Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J. Clin. Invest. 1993, 92(6), 2889-2896.
28. Ayo, S.H.; Radnik, R.; Garoni, J.A.; Troyer, D.A.; Kreisberg, D.I. High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell culture. Am. J. Physiol. 1991, 261(4Pt2), F571-F577.
29. Haneda, M.; Araki, S.; Togawa, M.; Sugimoto, T.; Isono, M.; Kikkawa, R. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 1997, 46(5), 847-853.
30. Ishii, H.; Jirousek, M.R.; Koya, D.; Takagi, C.; Xia, P.; Clermont, A.; Bursell, S.E.; Kern, T.S.; Ballas, L.M.; Health, W.F.; Stramm, L.E.; Feener, E.P.; King, G.L. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC inhibitor. Science 1996, 272(5262), 728-731.
31. Krump, E.; Borgeat, P. Adenosine. An endogenous inhibitor of arachidonic acid release and leukotriene biosynthesis in human neutrophils. Adv. Exp. Med. Biol. 1999, 447, 107-115.
32. Lewis, E.; Hunsicker, L.; Bain, R.; Rhode, R. The Effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 1993, 329(20), 1456-1462.
33. Mathiesen, E.R.; Hommel, E.; Hansen, H.P.; Parving, H.H. Preservation of normal GFR with long-term captopril treatment in normotensive IDDM patients with microalbuminuria. J. Am. Soc. Nephrol. 1997, 8, 115A.
34. Ichikawi, I.; Harris, R.C. Angiotensin actions in the kidney: Renewed insight into the old hormone. Kidney Int. 1991, 40(4), 583-596.
35. Egan, T.M.; Minta, J.O.; Scrimgeour, K.G.; Cooper, J.D. Captopril - A potential free radical scavenger: Inhibition of PMN NADPH oxidase. Clin. Invest. Med. 1988, 11(5), 351-356.
36. Rovin, B.H.; Dickerson, J.A.; Tan, L.C.; Fassler, J. Modulation of IL-1 induced chemokine expression in human mesangial cells through the alteration in redox status. Cytokine 1997, 9(3), 178-186.
37. Shan, Z.; Tan, D.; Satriano, D.; Silbiger, S.; Schlondorf, D. Intracellular glutathione influences collagen generation by mesangial cells. Kidney Int. 1994, 46(2), 388-395.
38. Chin, T.A.; Templeton, D.M. Protective elevations of glutathione and metallothionein in cadmium-expressed mesangial cells. Toxicology 1993, 29(1-2), 145-156.
39. Parks, L.D.; Zalups, R.K.; Barfuss, D.W. Heterogeneity of glutathione synthesis and secretion in the proximal tubule of the rabbit. Am. J. Physiol. 1998, 274(5), F924-F931.
40. Morgan, P.J. Molecular signaling via the melatonin receptor. Adv. Pineal Res. 1991, 5, 191-197.
41. Vanecek, J. Cellular mechanisms of melatonin action. Physiol. Rev. 1998, 78(3), 687-721.
42. Montilla, P.; Tunez, I.; Munoz, M.C.; Lopez, A.; Soria, J.V. Hyperlipidemic nephropathy induced by adriamycin: Effect of melatonin administration. Nephron 1997, 76(3), 345-350.
43. Daniels, W.M.; Reiter, R.J.; Melchiorri, D.; Sewerynek, E.; Pablos, M.I.; Ortiz, G.C. Melatonin counteracts lipid peroxidation induced by carbon tetrachloride but does not restore glucose-6 phosphatase activity. J. Pineal Res. 1995, 19(1), 1-6.
44. Sener, G.; Satiroglu, H.; Kabasakal, L.; Arbak, S.; Oner, S.; Ercan, F.; Keyer-Uysa, M. The protective effect of melatonin on cisplatin nephrotoxicity. Fundam. Clin. Pharmacol. 2000, 14(6), 553-560.
45. Ha, H.; Yu, M.R.; Kim, K.H. Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free Rad. Biol. Med. 1999, 26(7-8), 944-950.
46. Sugden, D.; Rowe, S.J. Protein kinase C activation antagonizes melatonininduced pigment activation in xenopus laevis melanophores. J. Cell. Biol. 1992, 119(6), 1515-1521.